Rozebalamin, an ultra-high dose vitamin B12 treatment, was approved in Japan to slow disease progression in people with ALS.

Eisai Co., Ltd. announced today that amyotrophic lateral sclerosis (ALS) treatment “Rozebalamin® for Injection 25 mg” ...

This is a news collection page for Darwin. Check this page for latest news headlines covering major stories, events from Darwin and surrounding Northern Territory. Get breaking news faster than ...

A 59-year-old Ridgetown woman faces a trafficking charge after a drug seizure Tuesday night. Approximately $36,000 worth of suspected cocaine and oxycodone were seized for analysis after the raid ...

When I reflect on my time as a caregiver to my late husband, Jeff, while we lived with his ALS, I remember how afraid I often felt. I was fearful of injuring him during a transfer. I dreaded making a ...

Eisai Co., Ltd. announced today that it has obtained manufacturing and marketing authorization approval for amyotrophic lateral sclerosis (ALS) treatment “Rozebalamin® for Injection 25 mg” ...

Eisai Co., Ltd. announced today that it has obtained manufacturing and marketing authorization approval for amyotrophic lateral sclerosis (ALS) treatment“Rozebalamin® for Injection 25 mg ...

Japanese drugmaker Eisai (TYO: 4523) closed down 2.3% at 5,587 yen today, despite news of regulatory approvals for two of its drugs. Eisai today revealed that it has obtained manufacturing and ...

Chengdu-based Clover Biopharmaceuticals is seeking to develop transformative biologic therapies for the millions of Chinese patients who currently do not have access to modern biological medicines.